{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:40:04Z","timestamp":1776487204350,"version":"3.51.2"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,4,15]]},"DOI":"10.2169\/internalmedicine.5985-25","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T22:07:15Z","timestamp":1756937235000},"page":"1120-1128","source":"Crossref","is-referenced-by-count":0,"title":["Male Sex, Diabetes Mellitus, and an Unvaccinated Status as Deteriorating Factors for Coronavirus Disease 2019 in Patients with Rheumatic Diseases: A Single-center Analysis in the North Kanto Region of Japan During the Omicron Variant Period"],"prefix":"10.2169","volume":"65","author":[{"given":"Fuminori","family":"Taniguchi","sequence":"first","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Komine","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Kondo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroi","family":"Kusaka","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kokuzawa","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kamata","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Nagatani","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Y\u00fcce M, Filiztekin E, \u00d6zkaya KG. COVID-19 diagnosis - a review of current methods. Biosens Bioelectron 172: 112752, 2021.","DOI":"10.1016\/j.bios.2020.112752"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Watanabe M. The COVID-19 pandemic in Japan. Surg Today 50: 787-793, 2020.","DOI":"10.1007\/s00595-020-02033-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. \u015eim\u015fek-Yavuz S. COVID-19: an update on epidemiology, prevention and treatment, September-2023. Infect Dis Clin Microbiol 5: 165-187, 2023.","DOI":"10.36519\/idcm.2023.251"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dhama K, Nainu F, Frediansyah A, et al. Global emerging Omicron variant of SARS-CoV-2: impacts, challenges and strategies. J Infect Public Health 16: 4-14, 2023.","DOI":"10.1016\/j.jiph.2022.11.024"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat Rev Rheumatol 18: 191-204, 2022.","DOI":"10.1038\/s41584-022-00755-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Oku K, Kimoto Y, Horiuchi T, et al. Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: results of a nationwide JCR COVID-19 registry in Japan. Mod Rheumatol 33: 768-776, 2023.","DOI":"10.1093\/mr\/roac104"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol 17: 71-72, 2021.","DOI":"10.1038\/s41584-020-00562-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kihara M, Sugihara T, Asano J, et al. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry. Clin Rheumatol 41: 3661-3673, 2022.","DOI":"10.1007\/s10067-022-06305-w"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Alhowaish TS, Alhamadh MS, Alhabeeb AY, Aldosari SF, Masuadi E, Alrashid A. Outcomes of COVID-19 in inflammatory rheumatic diseases: a retrospective cohort study. Cureus 14: e26343, 2022.","DOI":"10.7759\/cureus.26343"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Patil A, Chanakya K, Shenoy P, et al. A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases. BMC Rheumatol 6: 32, 2022.","DOI":"10.1186\/s41927-022-00264-0"},{"key":"11","unstructured":"11. Ministry of Health, Labour and Welfare. [Japan guidelines for the management of COVID-19. Version 10.1] [Internet]. Available from: https:\/\/www.mhlw.go.jp\/content\/001248424.pdf (in Japanese)"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 53: 737-754, 2021.","DOI":"10.1080\/23744235.2021.1924397"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kashiwado Y, Kimoto Y, Oku K, et al. Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: analysis of the JCR COVID-19 registry in Japan. Mod Rheumatol 34: 576-583, 2024.","DOI":"10.1093\/mr\/road057"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Montero F, Mart\u00ednez-Barrio J, Serrano-Benavente B, et al. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatol Int 40: 1593-1598, 2020.","DOI":"10.1007\/s00296-020-04676-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Horita N, Fukumoto T. Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic. J Med Virol 95: e28231, 2023.","DOI":"10.1002\/jmv.28231"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Brooks J, Montgomery A, Dalbeth N, et al. Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New Zealand. Lancet Reg Health West Pac 38: 100843, 2023.","DOI":"10.1016\/j.lanwpc.2023.100843"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Papagoras C, Zioga N, Papadopoulos V, et al. Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases. Clin Rheumatol 42: 3375-3385, 2023.","DOI":"10.1007\/s10067-023-06769-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kawamura S, Yamaguchi F, Kusakado R, et al. Changes in clinical features and severity of COVID-19 with the emergence of Omicron variants: a shift towards a common disease. Infect Drug Resist 17: 5595-5603, 2024.","DOI":"10.2147\/IDR.S492816"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Suzuki K, Ichikawa T, Suzuki S, Tanino Y, Kakinoki Y. Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan. PeerJ 10: e13762, 2022.","DOI":"10.7717\/peerj.13762"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Matsuda M, Funakubo Asanuma Y, Yokota K, et al. New-onset adult-onset Still's disease following COVID-19 vaccination: three case reports and a literature review. Intern Med 62: 299-305, 2023.","DOI":"10.2169\/internalmedicine.0590-22"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sato H, Nagatani K, Minota S. Diminished antibody response to SARS-CoV-2 in rheumatoid arthritis compared to metabolic disorders following the primary series of vaccinations and its recovery with a booster: a single-center prospective observational study. Int J Rheum Dis 27: e15203, 2024.","DOI":"10.1111\/1756-185X.15203"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Soy M, Keser G, Atagunduz P, et al. A practical approach for vaccinations including COVID-19 in autoimmune\/autoinflammatory rheumatic diseases: a non-systematic review. Clin Rheumatol 40: 3533-3545, 2021.","DOI":"10.1007\/s10067-021-05700-z"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lima-Mart\u00ednez MM, Carrera Boada C, Madera-Silva MD, Mar\u00edn W, Contreras M. COVID-19 and diabetes: a bidirectional relationship. Clin Investig Arterioscler 33: 151-157, 2021.","DOI":"10.1016\/j.artere.2021.04.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Santos CS, Morales CM, \u00c1lvarez ED, Castro C\u00c1, Robles AL, Sandoval TP. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol 39: 2789-2796, 2020.","DOI":"10.1007\/s10067-020-05301-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Gupta GS. The lactate and the lactate dehydrogenase in inflammatory diseases and major risk factors in COVID-19 patients. Inflammation 45: 2091-2123, 2022.","DOI":"10.1007\/s10753-022-01680-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Roongta R, Ghosh A. Managing rheumatoid arthritis during COVID-19. Clin Rheumatol 39: 3237-3244, 2020.","DOI":"10.1007\/s10067-020-05358-z"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/8\/65_5985-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:51:13Z","timestamp":1776484273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/8\/65_5985-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5985-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"5985-25"}}